These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1806545

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The cholesterol content in immune complexes as a marker of coronary and peripheral atherosclerosis].
    Kalenich OS, Tertov VV, Liakishev AA, Ruda MIa, Orekhov AN.
    Ter Arkh; 1991; 63(9):59-61. PubMed ID: 1759226
    [Abstract] [Full Text] [Related]

  • 4. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H.
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [Abstract] [Full Text] [Related]

  • 5. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
    Tedeschi-Reiner E, Reiner Z, Sonicki Z.
    Croat Med J; 2004 Jun; 45(3):333-7. PubMed ID: 15185429
    [Abstract] [Full Text] [Related]

  • 6. [Lipoprotein(a) as a biochemical marker of coronary atherosclerosis].
    Ezhov MV, Afanas'ev OI, Benevolenskaia GF, Savchenko AP, Liakishev AA, Pokrovskiĭ SN.
    Ter Arkh; 1997 Jun; 69(9):31-4. PubMed ID: 9411822
    [Abstract] [Full Text] [Related]

  • 7. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ.
    Arch Intern Med; 1996 Jun 10; 156(11):1181-8. PubMed ID: 8639012
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cholesterol and triglycerides in atherosclerosis: epidemiologic and physiopathologic considerations].
    Davidoff P.
    Rev Med Chil; 1991 Sep 10; 119(9):1050-8. PubMed ID: 1845100
    [Abstract] [Full Text] [Related]

  • 10. [From cholesterol to lipoprotein particle markers and/or risk factors].
    Fruchart JC, Cottet J.
    Bull Acad Natl Med; 1991 Jan 10; 175(1):51-62; discussion 62-5. PubMed ID: 1863858
    [Abstract] [Full Text] [Related]

  • 11. [Interpretation of B and A apoproteins dosage in the acute accidents of the cerebral and coronary atherosclerosis. Age influence upon the results (author's transl)].
    Bugugnani MJ, Haiat R, Fouyé H, Rémy A, Desoutter P.
    Ann Biol Clin (Paris); 1981 Jan 10; 39(3):131-4. PubMed ID: 6787958
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M, Stavljenić-Rukavina A, Sertić J, Zrinski R, Turek S, Grgac G, Ljubojević N.
    Coll Antropol; 1998 Jun 10; 22(1):149-55. PubMed ID: 10097431
    [Abstract] [Full Text] [Related]

  • 13. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
    Yoo WH.
    J Rheumatol; 2004 Sep 10; 31(9):1746-53. PubMed ID: 15338494
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan 10; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 15. [Pathogenetic significance of cholesterol-containing immune complexes and lipid peroxidation in ischemic heart disease].
    Urazgil'deeva SA, Shatalina LV, Gurevich VS.
    Ter Arkh; 1999 Jan 10; 71(12):8-10. PubMed ID: 10647190
    [Abstract] [Full Text] [Related]

  • 16. [Predictive value of plasma apolipoprotein B in myocardial infarction in young subjects. Correlations with coronarographic data].
    Douste-Blazy P, Solera ML, Delay M, De Graeve J, Valdiguie P, Marco J, Bernadet P.
    Arch Mal Coeur Vaiss; 1984 Jan 10; 77(1):21-6. PubMed ID: 6422890
    [Abstract] [Full Text] [Related]

  • 17. [Comparative study of lipids, apoproteins and lipoproteins in patients with coronary disease and in a control population].
    Marzullo C, Michotey O, Bourderont D, Levy J, Jung S, Tissot J, Huber-Braun C, Dorr R.
    Ann Biol Clin (Paris); 1994 Jan 10; 52(10):717-20. PubMed ID: 7747879
    [Abstract] [Full Text] [Related]

  • 18. The role of plasma lipids in carotid bifurcation atherosclerosis.
    Ford CS, Crouse JR, Howard G, Toole JF, Ball MR, Frye J.
    Ann Neurol; 1985 Mar 10; 17(3):301-3. PubMed ID: 3994317
    [Abstract] [Full Text] [Related]

  • 19. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.
    Gynecol Endocrinol; 2005 May 10; 20(5):258-63. PubMed ID: 16019370
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    Kacharava AG, Tertov VV, Orekhov AN.
    Ann Med; 1993 Dec 10; 25(6):551-5. PubMed ID: 8292305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.